Description
Variant summary: BTD c.1301A>G (p.Tyr434Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00026 in 251422 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in BTD causing Biotinidase Deficiency (0.00026 vs 0.0046), allowing no conclusion about variant significance. c.1301A>G has been reported in the literature in newborns with features of biotinidase deficiency to include cases where it was reported in cis with another presumably pathogenic variant (example, Akgun_2021, Seker-Yilmaz_2018, Ercan_2020, Procter_2016, Wolf_2005). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function in a homozygous genotype (Ercan_2020). The most pronounced variant effect results in 26%-36% of normal activity depending upon the methodology used. The following publications have been ascertained in the context of this evaluation (PMID: 26810761, 29353266, 33189081, 34448386, 15776412). ClinVar contains an entry for this variant (Variation ID: 458806). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
| # | Sample | Method | Observation |
|---|
| Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
|---|
| 1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |